enow.com Web Search

Search results

1. Results from the WOW.Com Content Network

2. Fibrate - Wikipedia

   en.wikipedia.org/wiki/Fibrate

   Fibrates may be compared to statin drugs, which reduce LDL-cholesterol (LDL-C) and have only limited effects on other lipid parameters. Clinical trials have shown that the combination of statins and fibrates results in a significantly greater reduction in LDL-C and triglyceride levels and greater increases in high-density lipoprotein ...

3. Lipid-lowering agent - Wikipedia

   en.wikipedia.org/wiki/Lipid-lowering_agent

   Lipid-lowering agents, also sometimes referred to as hypolipidemic agents, cholesterol-lowering drugs, or antihyperlipidemic agents are a diverse group of pharmaceuticals that are used to lower the level of lipids and lipoproteins, such as cholesterol, in the blood (hyperlipidemia). The American Heart Association recommends the descriptor ...

4. Ethyl eicosapentaenoic acid - Wikipedia

   en.wikipedia.org/wiki/Ethyl_eicosapentaenoic_acid

   On 13 December 2019, the FDA also approved Vascepa as the first drug specifically "to reduce cardiovascular risk among people with elevated triglyceride levels". [6] It is available as a generic medication. [8] In 2022, it was the 229th most commonly prescribed medication in the United States, with more than 1 million prescriptions. [9] [10]

5. Dyslipidemia: What Happens When Your Blood Fat Levels Are Off?

   www.aol.com/dyslipidemia-happens-blood-fat...

   High triglycerides. High total cholesterol (the sum of your LDL, HDL, and half your triglyceride levels) ... Statins are medications that can lower cholesterol by reducing the body's production of ...

6. Dyslipidemia: What It Is & How to Treat It - AOL

   www.aol.com/dyslipidemia-treat-105700223.html

   High triglycerides. High total cholesterol (the sum of your LDL, HDL, and half your triglyceride levels) ... Statins are medications that can lower cholesterol by reducing the body's production of ...

7. US FDA approves Ionis Pharma's genetic disorder drug - AOL

   www.aol.com/news/us-fda-approves-ionis-pharmas...

   Ionis' application for the drug was based on data from a late-stage study in which it helped reduce triglyceride levels by 44% in patients, compared to a placebo.